A Cedars-Sinai study has identified a previously unknown role for astrocyte cells in how the brain responds to damage and ...

Loan, 22, suffered a hemorrhagic stroke caused by a cerebral arteriovenous malformation and was saved by timely emergency intervention by doctors.

Gary Woodland returns to golf after surgery for a brain lesion and faces his father's lymphoma diagnosis. Joining the PNC Championship, Woodland finds solace in family and sport. Despite ongoing ...

Artificial intelligence is moving from the lab bench into the operating room, promising to spot and classify brain tumors with a level of speed and precision that would have sounded like science ...

After undergoing a CT scan, it was determined Collins had Stage 4 glioblastoma. Given the shape of his cancer, it could not be fully removed without Collins coming out of surgery "different," he told ...

Researchers at Thomas Jefferson University have developed a groundbreaking automated machine learning (AutoML) model that can accurately differentiate between two common types of brain tumors using ...

Imagine treating a brain disease with a jab in the arm instead of a hole in the skull. That’s the future a team at MIT is sketching out with a technology they call Circulatronics. It’s a mash-up of ...

Celebrity medium Tyler Henry is recovering after undergoing his second surgery in six months to treat a cyst growing on his brain. The Life After Death star’s husband Clint Godwin announced on Friday ...

Celebrity medium Tyler Henry is on the mend after undergoing his second brain surgery in six months, marking his third overall procedure since first being treated for a brain cyst at 18 years old.

The celebrity medium’s husband Clint Godwin shared that Tyler recently underwent a third brain operation—his second in six months—to address a cyst that had been growing and releasing fluid in his ...

A team of researchers at Massachusetts Institute of Technology (MIT) has been refining and combining several advanced technologies over the past six years to create a revolutionary platform to treat a ...

Zenas Biopharma’s autoimmune drug candidate has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study. The midstage MoonStone study saw 116 ...